These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 26821916)
21. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner. Zhao Z; de Beer MC; Cai L; Asmis R; de Beer FC; de Villiers WJ; van der Westhuyzen DR Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):168-73. PubMed ID: 15514202 [TBL] [Abstract][Full Text] [Related]
22. Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis. Luo Y; Duan H; Qian Y; Feng L; Wu Z; Wang F; Feng J; Yang D; Qin Z; Yan X Cell Res; 2017 Mar; 27(3):352-372. PubMed ID: 28084332 [TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible protein 2 Hig2/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice. Maier A; Wu H; Cordasic N; Oefner P; Dietel B; Thiele C; Weidemann A; Eckardt KU; Warnecke C FASEB J; 2017 Nov; 31(11):4971-4984. PubMed ID: 28760743 [TBL] [Abstract][Full Text] [Related]
24. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice. Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974 [TBL] [Abstract][Full Text] [Related]
25. Activation of soluble guanylyl cyclase prevents foam cell formation and atherosclerosis. Tsou CY; Chen CY; Zhao JF; Su KH; Lee HT; Lin SJ; Shyue SK; Hsiao SH; Lee TS Acta Physiol (Oxf); 2014 Apr; 210(4):799-810. PubMed ID: 24299003 [TBL] [Abstract][Full Text] [Related]
26. Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose. Hayek T; Hussein K; Aviram M; Coleman R; Keidar S; Pavoltzky E; Kaplan M Atherosclerosis; 2005 Nov; 183(1):25-33. PubMed ID: 16216589 [TBL] [Abstract][Full Text] [Related]
27. Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis. Tian FJ; An LN; Wang GK; Zhu JQ; Li Q; Zhang YY; Zeng A; Zou J; Zhu RF; Han XS; Shen N; Yang HT; Zhao XX; Huang S; Qin YW; Jing Q Cardiovasc Res; 2014 Jul; 103(1):100-10. PubMed ID: 24675724 [TBL] [Abstract][Full Text] [Related]
28. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice. Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619 [TBL] [Abstract][Full Text] [Related]
29. Reduction of Intracellular Chloride Concentration Promotes Foam Cell Formation. Wu QQ; Liu XY; Xiong LX; Shang JY; Mai XY; Pang RP; Su YX; Yu BX; Yuan JN; Yang C; Wang YL; Zhou P; Lv XF; Liu J; Zhou JG; Liang SJ Circ J; 2016; 80(4):1024-33. PubMed ID: 26911455 [TBL] [Abstract][Full Text] [Related]
30. Allergic asthma aggravated atherosclerosis increases cholesterol biosynthesis and foam cell formation in apolipoprotein E-deficient mice. Gao S; Wang C; Li W; Shu S; Zhou J; Yuan Z; Wang L Biochem Biophys Res Commun; 2019 Nov; 519(4):861-867. PubMed ID: 31558320 [TBL] [Abstract][Full Text] [Related]
31. Resistin-like molecule β is abundantly expressed in foam cells and is involved in atherosclerosis development. Kushiyama A; Sakoda H; Oue N; Okubo M; Nakatsu Y; Ono H; Fukushima T; Kamata H; Nishimura F; Kikuchi T; Fujishiro M; Nishiyama K; Aburatani H; Kushiyama S; Iizuka M; Taki N; Encinas J; Sentani K; Ogonuki N; Ogura A; Kawazu S; Yasui W; Higashi Y; Kurihara H; Katagiri H; Asano T Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1986-93. PubMed ID: 23702657 [TBL] [Abstract][Full Text] [Related]
32. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype. Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412 [TBL] [Abstract][Full Text] [Related]
33. Stimulatory effects of cardiotrophin 1 on atherosclerosis. Konii H; Sato K; Kikuchi S; Okiyama H; Watanabe R; Hasegawa A; Yamamoto K; Itoh F; Hirano T; Watanabe T Hypertension; 2013 Nov; 62(5):942-50. PubMed ID: 24041953 [TBL] [Abstract][Full Text] [Related]
34. Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors. Mäkinen PI; Lappalainen JP; Heinonen SE; Leppänen P; Lähteenvuo MT; Aarnio JV; Heikkilä J; Turunen MP; Ylä-Herttuala S Cardiovasc Res; 2010 Dec; 88(3):530-8. PubMed ID: 20634212 [TBL] [Abstract][Full Text] [Related]
35. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151 [TBL] [Abstract][Full Text] [Related]